Search research articles
Contact Us
Filters
Showing results (1-10 of 142) with videos related to
Page
of 15
Sort By:
Pathologie-Biologie
|
November 1, 1992
[Cancer of the breast in young women: should chemotherapy be intensified?]
M J Piccart
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
August 28, 2001
Proposed treatment guidelines for HER2-positive metastatic breast cancer in Europe
M J Piccart
Revue Medicale De Bruxelles
|
December 1, 1989
[Operable breast cancer without axillary node involvement: current therapeutic concepts]
M J Piccart
Cancer Treatment and Research
|
January 1, 1995
Taxoid compounds in breast cancer: current status and future prospects
M J Piccart
Bulletin Et Memoires De L'Academie Royale De Medecine De Belgique
|
February 16, 1999
["Taxanes: an action mechanism at the cellular level, significant clinical progress in the treatment of cancers of the ovary and breast"]
M J Piccart
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
September 27, 2012
Triple-negative breast cancer in focus: from biology to novel therapeutics. Editorial
M J Piccart
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
April 29, 1998
The changing landscape of breast cancer clinical research. ESMO-Award Lecture, ECCO-9 Hamburg, 18 September 1997
M J Piccart
Anti-Cancer Drugs
|
May 7, 2002
Herceptin: the future in adjuvant breast cancer therapy
M J Piccart-Gebhart
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
March 13, 1998
The bigger the better? ... or what we know and what we still need to learn about anthracycline dose per course, dose density and cumulative dose in the treatment of breast cancer
L Biganzoli, M J Piccart
Breast (Edinburgh, Scotland)
|
December 9, 2003
The best use of chemotherapy in the adjuvant setting
F Cardoso, M J Piccart
Page
of 15
Search research articles
Search
Showing results (1-10 of 142) with videos related to
Sort By:
Page
of 15
Pathologie-Biologie
|
November 1, 1992
[Cancer of the breast in young women: should chemotherapy be intensified?]
M J Piccart
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
August 28, 2001
Proposed treatment guidelines for HER2-positive metastatic breast cancer in Europe
M J Piccart
Revue Medicale De Bruxelles
|
December 1, 1989
[Operable breast cancer without axillary node involvement: current therapeutic concepts]
M J Piccart
Cancer Treatment and Research
|
January 1, 1995
Taxoid compounds in breast cancer: current status and future prospects
M J Piccart
Bulletin Et Memoires De L'Academie Royale De Medecine De Belgique
|
February 16, 1999
["Taxanes: an action mechanism at the cellular level, significant clinical progress in the treatment of cancers of the ovary and breast"]
M J Piccart
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
September 27, 2012
Triple-negative breast cancer in focus: from biology to novel therapeutics. Editorial
M J Piccart
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
April 29, 1998
The changing landscape of breast cancer clinical research. ESMO-Award Lecture, ECCO-9 Hamburg, 18 September 1997
M J Piccart
Anti-Cancer Drugs
|
May 7, 2002
Herceptin: the future in adjuvant breast cancer therapy
M J Piccart-Gebhart
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
March 13, 1998
The bigger the better? ... or what we know and what we still need to learn about anthracycline dose per course, dose density and cumulative dose in the treatment of breast cancer
L Biganzoli, M J Piccart
Breast (Edinburgh, Scotland)
|
December 9, 2003
The best use of chemotherapy in the adjuvant setting
F Cardoso, M J Piccart
Page
of 15